These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25499271)

  • 41. Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer.
    Rzyman W; Hagen OM; Dziadziuszko R; Kobierska-Gulida G; Karmolinski A; Lothe MI; Paleczka W; Murawski M; Jastrzebski T; Kopacz A; Jassem J; Skokowski J
    Eur J Surg Oncol; 2006 May; 32(4):462-5. PubMed ID: 16504458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylene blue-induced serotonin syndrome after left ventricular assist device implantation: A case report and literature review.
    Schumacher LD; Blumer V; Chaparro SV
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):e39-e43. PubMed ID: 28655448
    [No Abstract]   [Full Text] [Related]  

  • 43. Methylene blue as the safest blue dye for sentinel node mapping: emphasis on anaphylaxis reaction.
    Ramin S; Azar FP; Malihe H
    Acta Oncol; 2011 Jun; 50(5):729-31. PubMed ID: 21413854
    [No Abstract]   [Full Text] [Related]  

  • 44. [Serotonin syndrome during fluoxetine poisoning in a patient taking moclobemide].
    Chambost M; Liron L; Peillon D; Combe C
    Can J Anaesth; 2000 Mar; 47(3):246-50. PubMed ID: 10730736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer].
    Ge J; Yan B; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serotonin syndrome presenting as hypotonic coma and apnea: potentially fatal complications of selective serotonin receptor inhibitor therapy.
    Chechani V
    Crit Care Med; 2002 Feb; 30(2):473-6. PubMed ID: 11889332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In reference to Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use.
    Gillman K
    Laryngoscope; 2010 Feb; 120(2):436-7. PubMed ID: 19950381
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Generalized myoclonias related with combined fluoxetine and oral contraceptive intake].
    Cánovas D; Marco M; Sansa G
    Neurologia; 2005 Dec; 20(10):709. PubMed ID: 16317595
    [No Abstract]   [Full Text] [Related]  

  • 50. Meeting surgical necessities for sentinel lymph node biopsy in breast cancer: experience with methylene blue in a Colombian hospital.
    Angarita FA; Acuna SA; Cervera S; Torregrosa L; Tawil M
    Breast J; 2012; 18(6):618-9. PubMed ID: 23110749
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical efficacy of sentinel lymph node biopsy using methylene blue dye in clinically node-negative papillary thyroid carcinoma.
    Ji YB; Lee KJ; Park YS; Hong SM; Paik SS; Tae K
    Ann Surg Oncol; 2012 Jun; 19(6):1868-73. PubMed ID: 21989668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions.
    Callaway JC; Grob CS
    J Psychoactive Drugs; 1998; 30(4):367-9. PubMed ID: 9924842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease.
    Lauterbach EC
    Mov Disord; 1994 May; 9(3):343-6. PubMed ID: 8041377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of sentinel lymph node biopsy in early breast cancer.
    Patel NS; Sisodia VK; Vadher SH
    J Indian Med Assoc; 2014 Feb; 112(2):110-2. PubMed ID: 25935968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intraoperative methylene blue sentinel lymph node mapping in colorectal cancer.
    Chan SH; Ng C; Looi LM
    ANZ J Surg; 2008 Sep; 78(9):775-9. PubMed ID: 18844907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serotonin syndrome after cardiopulmonary bypass: a case demonstrating the interaction between methylene blue and selective serotonin reuptake inhibitors.
    Hanna ER; Clark JA
    A A Case Rep; 2014 May; 2(9):113-4. PubMed ID: 25611876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Sentinel lymph node identification with methylene blue in cervical cancer].
    Yuan SH; Liang LZ; Liu JH; Zhang HZ; Xiong Y; Yan XJ; Wei M; Zhang CQ
    Ai Zheng; 2004 Sep; 23(9):1089-92. PubMed ID: 15363209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer.
    Mostafa A; Carpenter R
    Eur J Surg Oncol; 2001 Sep; 27(6):610. PubMed ID: 11520102
    [No Abstract]   [Full Text] [Related]  

  • 60. Validation and feasibility of ex vivo sentinel lymph node "mapping" by methylene blue in colorectal cancer.
    Ceranic MS; Kecmanovic DM; Pavlov MJ; Nale DP; Micev MT; Kovacevic PA; Stamenkovic AB
    Hepatogastroenterology; 2010; 57(102-103):1113-8. PubMed ID: 21410041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.